Latest Articles

Publication Date
Metformin Plus IUD Well-Tolerated in EIN/Endometrial Cancer - Cancer Network

Metformin Plus IUD Well-Tolerated in EIN/Endometrial Cancer Cancer Network

Published: March 16, 2025, 7:52 p.m.
Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial - Nature.com

Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial Nature.com

Published: Feb. 20, 2025, 9:18 p.m.
Obesity-induced extracellular vesicles proteins drive the endometrial cancer pathogenesis: therapeutic potential of HO-3867 and Metformin - Nature.com

Obesity-induced extracellular vesicles proteins drive the endometrial cancer pathogenesis: therapeutic potential of HO-3867 and Metformin Nature.com

Published: Oct. 16, 2024, 2:34 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!